The level of open-market selling is minimal relative to company size and appears routine, possibly related to tax or portfolio management following equity vesting. Traders should not interpret this as a negative signal. Monitor for larger or sustained selling patterns.
Price Chart
Executive Summary
Three United Therapeutics insiders, including the CEO and CFO, conducted open-market share sales totaling $158K over a 7-day period, concurrent with derivative exercises. The open-market selling is modest in magnitude relative to the company's $25.3B market cap.
Key Financial Metrics
Key Facts
- CEO Martine Rothblatt sold $271K worth of shares in two transactions ($20K on 2026-04-13 and $251K on 2026-04-10), but only $20K is from open-market selling; the rest stems from derivative exercises.
- EVP Paul Mahon sold $115K in open-market shares, following derivative exercises of 8,300 shares.
- CFO James Edgemond sold $23K in open-market shares, alongside derivative exercises of 20,000 shares.
- Total open-market selling by insiders: $158K over 7 days.
- All open-market sales represent less than 0.001% of United Therapeutics' $25.3B market cap.
Financial Impact
$158,000 in open-market selling over 7 days (<0.001% of market cap)
Risk Factors
- Perception risk if media mischaracterizes derivative exercises as insider selling.
- Potential for increased scrutiny if future filings show accelerating open-market dispositions.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-UTHR-1776371482368 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | Insider Cluster | $500.35 $497.31 | ▼ −0.61% | ▼ −2.72% | $571.38 (+14.20%) |
Sep 11, 2026 21d ago | Insider Cluster | $497.11 $494.63 | ▼ −0.50% | ▼ −0.28% | $571.38 (+14.94%) |
Sep 10, 2026 22d ago | Insider Cluster | $503.86 $497.27 | ▼ −1.31% | ▼ −0.81% | $571.38 (+13.40%) |
Sep 9, 2026 23d ago | Insider Cluster | $506.82 $498.48 | ▼ −1.65% | ▼ −0.99% | $571.38 (+12.74%) |
Sep 4, 2026 28d ago | Insider Cluster | $487.61 $502.70 | ▲ +3.09% | ▲ +4.30% | $571.38 (+17.18%) |
Sep 3, 2026 29d ago | Insider Cluster | $488.16 $497.11 | ▲ +1.83% | ▲ +2.98% | $571.38 (+17.05%) |
Aug 28, 2026 5w ago | Insider Cluster | $515.46 $487.61 | ▼ −5.40% | ▼ −5.51% | $571.38 (+10.85%) |
Aug 27, 2026 5w ago | Insider Cluster | $527.91 $492.02 | ▼ −6.80% | ▼ −6.03% | $571.38 (+8.23%) |
Aug 26, 2026 5w ago | Insider Cluster | $516.68 $492.02 | ▼ −4.77% | ▼ −4.65% | $571.38 (+10.59%) |
Aug 25, 2026 5w ago | Insider Cluster | $516.68 $492.02 | ▼ −4.77% | ▼ −4.65% | $571.38 (+10.59%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access